PUBLISHER: The Insight Partners | PRODUCT CODE: 1494292
PUBLISHER: The Insight Partners | PRODUCT CODE: 1494292
Middle East & Africa Coagulation Market Forecast to 2030 - Regional Analysis - by Disease Indications, Type, Offering, Technology, and End User
The Middle East & Africa coagulation market was valued at US$ 291.47 million in 2022 and is expected to reach US$ 467.78 million by 2030; it is estimated to grow at a CAGR of 6.1% from 2022 to 2030.
Development of Point-of-Care (POC) Coagulation Analyzers Fuel Middle East & Africa Coagulation Market
A rapid, reliable assessment of hemostasis is essential for patients suffering from trauma or other bleeding problems. Due to the constraints of sample preparation and analytical process, routine coagulation assays cannot analyze clot formation, and their results can be obtained only after 30-90 minutes. POC devices such as platelet function test, viscoelastic coagulation tests, blood gas analysis, and other coagulometers are available for assessment of hemostasis. A POC measurement tool can be used inside and outside the hospital as a decision-making and management tool. When time is paramount, POC analyzers provide immediate, actionable results in emergency rooms, coronary care units, surgery, and procedure suites. In addition to outpatient clinics and physicians' offices, these devices can assist in patient management in pharmacies, care centers, and patients' homes. POC coagulation analyzers offer timely results without compromising diagnostic quality control provided by central labs. In POC testing, it is important to provide fast results, along with accuracy and quality assurance.
In 2021, Siemens Healthineers launched fully automated CN-3000 and CN-6000 systems, which are mid- and high-volume handheld POC coagulation testing devices. The FDA cleared Siemens Healthineers' Xprecia Stride Coagulation Analyser in 2016, as a POC coagulation analyzer device. The device has demonstrated prothrombin time/international normalized ratio (PT/INR) testing performance equivalence to Roche CoaguChek XS.
Thus, the growing developments in POC coagulation analyzers are expected to boost the coagulation market growth during the forecast period.
Middle East & Africa Coagulation Market Overview
The Middle East & Africa coagulation market has been segmented into the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa. Market growth in this region is mainly ascribed to developments in medical facilities, the increasing prevalence of blood disorders, and the growing incidence of AFib and other cardiovascular diseases.
Saudi Arabia is one of the important Middle Eastern countries with significant scope for the coagulation market. According to the "Assessment of Venous Thromboembolism Awareness in Makkah, Saudi Arabia" study, venous thromboembolism affects ~25,000 people in Saudi Arabia every year. As per the article "Prevalence of venous thromboembolism in patients with acetabular or hip fractures," published in the Journal of Musculoskeletal Surgery and Research in 2020, the prevalence of hospital-acquired deep vein thrombosis in Saudi Arabia ranges from 10% to 40% in surgical and medical patients. Venous thromboembolism and deep vein thrombosis is a condition where blood clot occurs in the body part such as the deep vein. Thus, the increasing prevalence of blood disorders such as venous thromboembolism, hemophilia, and clotting factor diseases is fueling the growth of the market in Saudi Arabia.
Middle East & Africa Coagulation Market Revenue and Forecast to 2030 (US$ Million)
Middle East & Africa Coagulation Market Segmentation
The Middle East & Africa coagulation market is segmented based on disease indication, type, offering, technology, end user, and country.
Based on disease indication, the Middle East & Africa coagulation market is segmented into vitamin k deficiency, liver disease, disseminated intravascular coagulation and pulmonary embolism, development of circulating anticoagulants, hemophilia, von willebrand's disease, and others. The liver disease segment held the largest Middle East & Africa coagulation market share in 2022.
Based on type, the Middle East & Africa coagulation market is bifurcated into clinical laboratory analysers and point-of-care testing analyzers. The clinical laboratory analysers segment held a larger Middle East & Africa coagulation market share in 2022. Clinical laboratory analysers segment is further subsegmented into controls & calibrators, assays & reagents, instruments/systems, coagulation factors, and others.
In terms of offering, the Middle East & Africa coagulation market is bifurcated into diagnosis and treatment. The diagnosis segment held a larger Middle East & Africa coagulation market share in 2022. Diagnosis segment is further subsegmented into prothrombin time testing, fibrinogen testing, activated clotting time testing, activated partial thromboplastin time testing, d-dimmer testing, platelets function testing, and others. Treatment segment is further subsegmented into anti-fibrinolytic drugs, birth control pills, desmopressin & immunosuppressive medicines, vitamin k supplements, blood thinners, thrombin inhibitors or thrombolytics, replacement therapy, catheter-assisted thrombus removal, and others.
By technology, the Middle East & Africa coagulation market is segmented into optical technology, mechanical technology, electrochemical technology, and others. The optical technology segment held the largest Middle East & Africa coagulation market share in 2022.
By end user, the Middle East & Africa coagulation market is segmented into clinical laboratories, hospitals, and others. The hospitals segment held the largest Middle East & Africa coagulation market share in 2022.
Based on country, the Middle East & Africa coagulation market is categorized into the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa. Saudi Arabia dominated the Middle East & Africa coagulation market in 2022.
Siemens Healthineers AG; ImproGen Diagnostik Kimya San & Tic Ltd ?ti; Sysmex Corp; F. Hoffmann-La Roche Ltd; Genrui Biotech Co Ltd; Transasia Bio-Medicals Ltd; and Horiba Ltd are some of the leading companies operating in the Middle East & Africa coagulation market.
Table Of Contents
1. Introduction
- 1.1 The Insight Partners Research Report Guidance
- 1.2 Market Segmentation
2. Executive Summary
- 2.1 Key Insights
3. Research Methodology
- 3.1 Coverage
- 3.2 Secondary Research
- 3.3 Primary Research
4. Middle East & Africa Coagulation Market - Key Industry Dynamics
- 4.1 Key Market Drivers:
- 4.1.1 Increasing Prevalence of Blood Disorders
- 4.1.2 Rising Prevalence of Cardiovascular Diseases
- 4.2 Market Restraints
- 4.2.1 High Costs Associated with Coagulation Analyzers
- 4.3 Market Opportunities
- 4.3.1 Growing Organic and Inorganic Strategies by Key Market Players
- 4.4 Future Trends
- 4.4.1 Development of Point-of-Care (POC) Coagulation Analyzers
- 4.5 Impact Analysis
5. Coagulation Market - Middle East & Africa Market Analysis
- 5.1 Middle East & Africa Coagulation Market Revenue (US$ million), 2022 - 2030
6. Middle East & Africa Coagulation Market - Revenue and Forecast to 2030 - by Disease Indication
- 6.1 Overview
- 6.2 Middle East & Africa Coagulation Market Revenue Share, by Disease Indication 2022 & 2030 (%)
- 6.3 Vitamin K Deficiency
- 6.3.1 Overview
- 6.3.2 Vitamin K Deficiency: Middle East & Africa Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
- 6.4 Liver Disease
- 6.4.1 Overview
- 6.4.2 Liver Disease: Middle East & Africa Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
- 6.5 Disseminated Intravascular Coagulation and Pulmonary Embolism
- 6.5.1 Overview
- 6.5.2 Disseminated Intravascular Coagulation and Pulmonary Embolism: Middle East & Africa Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
- 6.6 Development of Circulating Anticoagulant
- 6.6.1 Overview
- 6.6.2 Development of Circulating Anticoagulant: Middle East & Africa Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
- 6.7 Hemophilia
- 6.7.1 Overview
- 6.7.2 Hemophilia: Middle East & Africa Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
- 6.8 Von Willebrand's Disease
- 6.8.1 Overview
- 6.8.2 Von Willebrand's Disease: Middle East & Africa Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
- 6.9 Others
- 6.9.1 Overview
- 6.9.2 Others: Middle East & Africa Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
7. Middle East & Africa Coagulation Market - Revenue and Forecast to 2030 - by Type
- 7.1 Overview
- 7.2 Middle East & Africa Coagulation Market Revenue Share, by Type 2022 & 2030 (%)
- 7.3 Clinical Laboratory Analyzers
- 7.3.1 Overview
- 7.3.2 Clinical Laboratory Analyzers: Middle East & Africa Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
- 7.3.2.1 Middle East & Africa Coagulation Market, by Clinical Laboratory Analyzers
- 7.4 Point-of-Care Testing Analyzers
- 7.4.1 Overview
- 7.4.2 Point-of-Care Testing Analyzers: Middle East & Africa Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
8. Middle east & Africa Coagulation Market - Revenue and Forecast to 2030 - by Offering
- 8.1 Overview
- 8.2 Middle East & Africa Coagulation Market Revenue Share, by Offering 2022 & 2030 (%)
- 8.3 Diagnosis
- 8.3.1 Overview
- 8.3.2 Diagnosis: Middle East & Africa Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
- 8.3.2.1 Middle East & Africa Coagulation Market, by Diagnosis
- 8.4 Treatment
- 8.4.1 Overview
- 8.4.2 Treatment: Middle East & Africa Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
- 8.4.2.1 Middle East & Africa Coagulation Market, by Treatment
9. Middle East & Africa Coagulation Market - Revenue and Forecast to 2030 - by Technology
- 9.1 Overview
- 9.2 Middle East & Africa Coagulation Market Revenue Share, by Technology 2022 & 2030 (%)
- 9.3 Optical Technology
- 9.3.1 Overview
- 9.3.2 Optical Technology: Middle East & Africa Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
- 9.4 Mechanical Technology
- 9.4.1 Overview
- 9.4.2 Mechanical Technology: Middle East & Africa Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
- 9.5 Electrochemical Technology
- 9.5.1 Overview
- 9.5.2 Electrochemical Technology: Middle East & Africa Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
- 9.6 Others
- 9.6.1 Overview
- 9.6.2 Others: Middle East & Africa Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
10. Middle East & Africa Coagulation Market - Revenue and Forecast to 2030 - by End User
- 10.1 Overview
- 10.2 Middle East & Africa Coagulation Market Revenue Share, by End User 2022 & 2030 (%)
- 10.3 Clinical Laboratories
- 10.3.1 Overview
- 10.3.2 Clinical Laboratories: Middle East & Africa Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
- 10.4 Hospitals
- 10.4.1 Overview
- 10.4.2 Hospitals: Middle East & Africa Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
- 10.5 Others
- 10.5.1 Overview
- 10.5.2 Others: Middle East & Africa Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
11. Middle East & Africa Coagulation Market - Country Analysis
- 11.1 Middle East & Africa Coagulation Market, Revenue and Forecast to 2030
- 11.1.1.1 Middle East & Africa Coagulation Market by Country
- 11.1.1.2 Saudi Arabia
- 11.1.1.2.1 Overview
- 11.1.1.2.2 Saudi Arabia Coagulation Market Revenue and Forecast to 2030 (US$ million)
- 11.1.1.2.3 Saudi Arabia Coagulation Market, by Disease Indication
- 11.1.1.2.4 Saudi Arabia Coagulation Market, by Type
- 11.1.1.2.4.1 Saudi Arabia Coagulation Market, by Clinical Laboratory Analyzer
- 11.1.1.2.5 Saudi Arabia Coagulation Market, by Offering
- 11.1.1.2.5.1 Saudi Arabia Coagulation Market, by Diagnosis
- 11.1.1.2.5.2 Saudi Arabia Coagulation Market, by Treatment
- 11.1.1.2.6 Saudi Arabia Coagulation Market, by Technology
- 11.1.1.2.7 Saudi Arabia Coagulation Market, by End User
- 11.1.1.3 South Africa
- 11.1.1.3.1 Overview
- 11.1.1.3.2 South Africa Coagulation Market Revenue and Forecast to 2030 (US$ million)
- 11.1.1.3.3 South Africa Coagulation Market, by Disease Indication
- 11.1.1.3.4 South Africa Coagulation Market, by Type
- 11.1.1.3.4.1 South Africa Coagulation Market, by Clinical Laboratory Analyzer
- 11.1.1.3.5 South Africa Coagulation Market, by Offering
- 11.1.1.3.5.1 South Africa Coagulation Market, by Diagnosis
- 11.1.1.3.5.2 South Africa Coagulation Market, by Treatment
- 11.1.1.3.6 South Africa Coagulation Market, by Technology
- 11.1.1.3.7 South Africa Coagulation Market, by End User
- 11.1.1.4 UAE
- 11.1.1.4.1 Overview
- 11.1.1.4.2 UAE Coagulation Market Revenue and Forecast to 2030 (US$ million)
- 11.1.1.4.3 UAE Coagulation Market, by Disease Indication
- 11.1.1.4.4 UAE Coagulation Market, by Type
- 11.1.1.4.4.1 UAE Coagulation Market, by Clinical Laboratory Analyzer
- 11.1.1.4.5 UAE Coagulation Market, by Offering
- 11.1.1.4.5.1 UAE Coagulation Market, by Diagnosis
- 11.1.1.4.5.2 UAE Coagulation Market, by Treatment
- 11.1.1.4.6 UAE Coagulation Market, by Technology
- 11.1.1.4.7 UAE Coagulation Market, by End User
- 11.1.1.5 Rest of Middle East & Africa
- 11.1.1.5.1 Overview
- 11.1.1.5.2 Rest of Middle East & Africa Coagulation Market Revenue and Forecast to 2030 (US$ million)
- 11.1.1.5.3 Rest of Middle East & Africa Coagulation Market, by Disease Indication
- 11.1.1.5.4 Rest of Middle East & Africa Coagulation Market, by Type
- 11.1.1.5.4.1 Rest of Middle East & Africa Coagulation Market, by Clinical Laboratory Analyzer
- 11.1.1.5.5 Rest of Middle East & Africa Coagulation Market, by Offering
- 11.1.1.5.5.1 Rest of Middle East & Africa Coagulation Market, by Diagnosis
- 11.1.1.5.5.2 Rest of Middle East & Africa Coagulation Market, by Treatment
- 11.1.1.5.6 Rest of Middle East & Africa Coagulation Market, by Technology
- 11.1.1.5.7 Rest of Middle East & Africa Coagulation Market, by End User
12. Coagulation Market-Industry Landscape
- 12.1 Overview
- 12.2 Growth Strategies in the Coagulation Market
- 12.3 Inorganic Growth Strategies
- 12.3.1 Overview
- 12.4 Organic Growth Strategies
- 12.4.1 Overview
13. Company Profiles
- 13.1 Siemens Healthineers AG
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
- 13.2 ImproGen Diagnostik Kimya San. & Tic. Ltd.Sti.
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
- 13.3 Sysmex Corp
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
- 13.4 F. Hoffmann-La Roche Ltd
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
- 13.5 Genrui Biotech Co., Ltd.
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
- 13.6 Transasia Bio-Medicals Ltd
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
- 13.7 Horiba Ltd.
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
14. Appendix
- 14.1 About Us
- 14.2 Glossary of Terms
List Of Tables
- Table 1. Middle East & Africa Coagulation Market Segmentation
- Table 2. Coagulation Market Revenue and Forecast to 2030 (US$ million) - Clinical Laboratory Analyzers
- Table 3. Middle East & Africa Coagulation Market Revenue and Forecast to 2030 (US$ million) - Diagnosis
- Table 4. Middle East & Africa Coagulation Market Revenue and Forecast to 2030 (US$ million) - Treatment
- Table 5. Optical Technologies and Their Applications
- Table 6. Mechanical Technologies and Their Applications
- Table 7. Saudi Arabia Coagulation Market Revenue and Forecast to 2030 (US$ million) - Disease Indication
- Table 8. Saudi Arabia Coagulation Market Revenue and Forecast to 2030 (US$ million) - Type
- Table 9. Saudi Arabia Coagulation Market Revenue and Forecast to 2030 (US$ million) - Clinical Laboratory Analyzer
- Table 10. Saudi Arabia Coagulation Market Revenue and Forecast To 2030 (US$ million) - Offering
- Table 11. Saudi Arabia Coagulation Market Revenue and Forecast to 2030 (US$ million) - Diagnosis
- Table 12. Saudi Arabia Coagulation Market Revenue and Forecast to 2030 (US$ million) - Treatment
- Table 13. Saudi Arabia Coagulation Market Revenue and Forecast To 2030 (US$ million) - Technology
- Table 14. Saudi Arabia Coagulation Market Revenue and Forecast To 2030 (US$ million) - End User
- Table 15. South Africa Coagulation Market Revenue and Forecast to 2030 (US$ million) - Disease Indication
- Table 16. South Africa Coagulation Market Revenue and Forecast to 2030 (US$ million) - Type
- Table 17. South Africa Coagulation Market Revenue and Forecast to 2030 (US$ million) - Clinical Laboratory Analyzer
- Table 18. South Africa Coagulation Market Revenue and Forecast To 2030 (US$ million) - Offering
- Table 19. South Africa Coagulation Market Revenue and Forecast to 2030 (US$ million) - Diagnosis
- Table 20. South Africa Coagulation Market Revenue and Forecast to 2030 (US$ million) - Treatment
- Table 21. South Africa Coagulation Market Revenue and Forecast To 2030 (US$ million) - Technology
- Table 22. South Africa Coagulation Market Revenue and Forecast To 2030 (US$ million) - End User
- Table 23. UAE Coagulation Market Revenue and Forecast to 2030 (US$ million) - Disease Indication
- Table 24. UAE Coagulation Market Revenue and Forecast to 2030 (US$ million) - Type
- Table 25. UAE Coagulation Market Revenue and Forecast to 2030 (US$ million) - Clinical Laboratory Analyzer
- Table 26. UAE Coagulation Market Revenue and Forecast To 2030 (US$ million) - Offering
- Table 27. UAE Coagulation Market Revenue and Forecast to 2030 (US$ million) - Diagnosis
- Table 28. UAE Coagulation Market Revenue and Forecast to 2030 (US$ million) - Treatment
- Table 29. UAE Coagulation Market Revenue and Forecast To 2030 (US$ million) - Technology
- Table 30. UAE Coagulation Market Revenue and Forecast To 2030 (US$ million) - End User
- Table 31. Rest of Middle East & Africa Coagulation Market Revenue and Forecast to 2030 (US$ million) - Disease Indication
- Table 32. Rest of Middle East & Africa Coagulation Market Revenue and Forecast to 2030 (US$ million) - Type
- Table 33. Rest of Middle East & Africa Coagulation Market Revenue and Forecast to 2030 (US$ million) - Clinical Laboratory Analyzer
- Table 34. Rest of Middle East & Africa Coagulation Market Revenue and Forecast To 2030 (US$ million) - Offering
- Table 35. Rest of Middle East & Africa Coagulation Market Revenue and Forecast to 2030 (US$ million) - Diagnosis
- Table 36. Rest of Middle East & Africa Coagulation Market Revenue and Forecast to 2030 (US$ million) - Treatment
- Table 37. Rest of Middle East & Africa Coagulation Market Revenue and Forecast To 2030 (US$ million) - Technology
- Table 38. Rest of Middle East & Africa Coagulation Market Revenue and Forecast To 2030 (US$ million) - End User
- Table 39. Recent Inorganic Growth Strategies in the Coagulation Market
- Table 40. Recent Organic Growth Strategies in the Coagulation Market
- Table 41. Glossary of Terms, Coagulation Market
List Of Figures
- Figure 1. Middle East & Africa Coagulation Market Segmentation, By Country
- Figure 2. Middle East & Africa Coagulation Market - Key Industry Dynamics
- Figure 3. Impact Analysis of Drivers and Restraints
- Figure 4. Middle East & Africa Coagulation Market Revenue (US$ million), 2020 - 2030
- Figure 5. Middle East & Africa Coagulation Market Revenue Share, by Disease Indication 2022 & 2030 (%)
- Figure 6. Vitamin K Deficiency: Middle East & Africa Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
- Figure 7. Liver Disease: Middle East & Africa Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
- Figure 8. Disseminated Intravascular Coagulation and Pulmonary Embolism: Middle East & Africa Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
- Figure 9. Development of Circulating Anticoagulant: Middle East & Africa Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
- Figure 10. Hemophilia: Middle East & Africa Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
- Figure 11. Von Willebrand's Disease: Middle East & Africa Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
- Figure 12. Others: Middle East & Africa Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
- Figure 13. Middle East & Africa Coagulation Market Revenue Share, by Type 2022 & 2030 (%)
- Figure 14. Clinical Laboratory Analyzers: Middle East & Africa Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
- Figure 15. Point-of-Care Testing Analyzers: Middle East & Africa Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
- Figure 16. Middle East & Africa Coagulation Market Revenue Share, by Offering 2022 & 2030 (%)
- Figure 17. Diagnosis: Middle East & Africa Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
- Figure 18. Treatment: Middle East & Africa Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
- Figure 19. Middle East & Africa Coagulation Market Revenue Share, by Technology 2022 & 2030 (%)
- Figure 20. Optical Technology: Middle East & Africa Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
- Figure 21. Mechanical Technology: Middle East & Africa Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
- Figure 22. Electrochemical Technology: Middle East & Africa Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
- Figure 23. Others: Middle East & Africa Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
- Figure 24. Middle East & Africa Coagulation Market Revenue Share, by End User 2022 & 2030 (%)
- Figure 25. Clinical Laboratories: Middle East & Africa Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
- Figure 26. Hospitals: Middle East & Africa Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
- Figure 27. Others: Middle East & Africa Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
- Figure 28. Coagulation Market, By Country (2022) (US$ million)
- Figure 29. Middle East & Africa Coagulation Market, By Key Countries, 2022 and 2030 (%)
- Figure 30. Saudi Arabia Coagulation Market Revenue and Forecast to 2030 (US$ million)
- Figure 31. South Africa Coagulation Market Revenue and Forecast to 2030 (US$ million)
- Figure 32. UAE Coagulation Market Revenue and Forecast to 2030 (US$ million)
- Figure 33. Rest of Middle East & Africa Coagulation Market Revenue and Forecast to 2030 (US$ million)
- Figure 34. Growth Strategies in the Coagulation Market
